194853795	194853795	CD	B-NP	O
|	|	NN	I-NP	O
BCRHC	BCRHC	NN	I-NP	O
|	|	NN	I-NP	O
64414838	64414838	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0885146	0885146	CD	B-NP	O
|	|	CC	I-NP	O
2/15/2006	2/15/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
noncardiac	noncardiac	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/15/2006	2/15/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/28/2007	10/28/2007	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-NP	O
LATZ	LATZ	NN	I-NP	B-protein
,	,	,	O	O
ADOLFO	ADOLFO	NNP	B-NP	O
919-80-22-6	919-80-22-6	CD	I-NP	O
New	New	NNP	I-NP	O
Win	Win	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
7/9/07	7/9/07	CD	B-NP	O
AT	AT	NN	I-NP	O
02	02	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
Attending	Attend	VBG	B-VP	O
evaluation	evaluation	NN	B-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
GAINEY	GAINEY	NN	B-NP	O
,	,	,	O	O
RALEIGH	RALEIGH	NNP	B-NP	O
JAN	JAN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ALPRAZOLAM	ALPRAZOLAM	NN	B-NP	O
1	1	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
Anxiety	Anxiety	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
on	on	IN	B-PP	O
q4	q4	NN	B-NP	O
hours	hour	NNS	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	B-protein
ASCORBIC	ASCORBIC	NN	I-NP	I-protein
ACID	ACID	NN	I-NP	I-protein
500	500	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
ASPIRIN	ASPIRIN	NNP	I-NP	I-protein
ENTERIC	ENTERIC	NNP	I-NP	I-protein
COATED	COATED	VBD	B-VP	I-protein
325	325	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/6/06	11/6/06	CD	B-NP	O
by	by	IN	B-PP	O
DEMPEWOLF	DEMPEWOLF	NN	B-NP	O
,	,	,	O	O
ALFONZO	ALFONZO	NNP	B-NP	O
T.	T.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
691057523	691057523	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
IBUPROFEN	IBUPROFEN	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
GI	GI	NN	B-NP	O
upset	upset	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
KETOROLAC	KETOROLAC	NN	B-NP	O
TROMETHAMINE	TROMETHAMINE	NN	I-NP	O
;	;	:	O	O
reactions	reaction	NNS	B-NP	O
are	be	VBP	B-VP	O
Rash	Rash	NNP	B-NP	O
,	,	,	O	O
GI	GI	NNP	B-NP	O
upset	upset	VBD	B-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
NSAIDs	NSAID	NNS	B-NP	O
;	;	:	O	O
reactions	reaction	NNS	B-NP	O
are	be	VBP	B-VP	O
GI	GI	NNP	B-NP	O
upset	upset	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
tolerates	tolerate	VBZ	B-VP	O
home	home	NN	B-NP	O
asa	asa	NN	I-NP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
needs	need	VBZ	B-VP	O
DULCOLAX	DULCOLAX	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
BISACODYL	BISACODYL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NNP	I-NP	O
75	75	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
0.125	0.125	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	B-NP	O
60	60	CD	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/6/06	11/6/06	CD	B-NP	O
by	by	IN	B-PP	O
DEVIS	DEVIS	NN	B-NP	O
,	,	,	O	O
BOBBIE	BOBBIE	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
COLACE	COLACE	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/6/06	11/6/06	CD	B-NP	O
by	by	IN	B-PP	O
AESCHBACHER	AESCHBACHER	NN	B-NP	O
,	,	,	O	O
AVERY	AVERY	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
FUROSEMIDE	FUROSEMIDE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
236121642	236121642	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
DYAZIDE	DYAZIDE	NN	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
SOB	SOB	NN	B-NP	B-protein
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
IMDUR	IMDUR	NN	B-NP	O
ER	ER	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
ISOSORBIDE	ISOSORBIDE	NN	I-NP	B-protein
MONONITRATE	MONONITRATE	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
SR	SR	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
30	30	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Give	Give	NN	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
50	50	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
11/6/06	11/6/06	CD	B-NP	O
by	by	IN	B-PP	O
SCHNETTLER	SCHNETTLER	NN	B-NP	O
,	,	,	O	O
CHAD	CHAD	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
DIGOXIN	DIGOXIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
181444016	181444016	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
LEVOTHYROXINE	LEVOTHYROXINE	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
&	&	CC	I-NP	O
DIGOXIN	DIGOXIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
LIDOCAINE	LIDOCAINE	NN	B-NP	O
5	5	CD	B-NP	O
%	%	NN	I-NP	O
PATCH	PATCH	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
on	on	IN	B-PP	O
for	for	IN	B-PP	O
12	12	CD	B-NP	O
hours	hour	NNS	I-NP	O
,	,	,	O	O
off	off	RB	B-ADVP	O
for	for	IN	B-PP	O
12	12	CD	B-NP	O
hours	hour	NNS	I-NP	O
-	-	:	O	O
on	on	IN	B-PP	O
2	2	CD	B-NP	O
patches	patch	NNS	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
TOPROL	TOPROL	NN	I-NP	O
XL	XL	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
50	50	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

MS	MS	NN	B-NP	O
CONTIN	CONTIN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
MORPHINE	MORPHINE	NN	I-NP	O
CONTROLLED	CONTROLLED	VBD	B-VP	O
RELEASE	RELEASE	NN	B-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	O
30	30	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
oversedation	oversedation	NN	B-NP	O
,	,	,	O	O
RR	RR	NN	B-NP	B-protein
<	<	SYM	B-NP	I-protein
10	10	CD	B-NP	I-protein
OXYCODONE	OXYCODONE	NN	I-NP	I-protein
30	30	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
Q4H	Q4H	NNP	I-NP	I-protein
PRN	PRN	NNP	I-NP	I-protein
Pain	Pain	NNP	I-NP	I-protein
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
lethargic	lethargic	JJ	B-NP	O
,	,	,	I-NP	O
rr	rr	NN	I-NP	B-protein
<	<	SYM	O	I-protein
20	20	CD	B-NP	I-protein
PREGABALIN	PREGABALIN	NN	I-NP	I-protein
150	150	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
11/6/06	11/6/06	CD	B-NP	O
by	by	IN	B-PP	O
PLATT	PLATT	NNP	B-NP	O
,	,	,	O	O
VICTOR	VICTOR	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
PREGABALIN	PREGABALIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
402113327	402113327	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
GABAPENTIN	GABAPENTIN	NN	B-NP	B-protein
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
alopecia	alopecia	RB	B-ADVP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
tolerates	tolerate	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
Number	Number	NN	I-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
SENNA	SENNA	NN	I-NP	O
TABLETS	TABLETS	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
SENNOSIDES	SENNOSIDES	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
2	2	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BEDTIME	BEDTIME	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
diarrhea	diarrhea	NN	B-NP	O
SIMVASTATIN	SIMVASTATIN	NN	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

SODIUM	SODIUM	NN	B-NP	B-protein
CHLORIDE	CHLORIDE	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
GM	GM	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
TID	TID	NNP	I-NP	O
VANCOMYCIN	VANCOMYCIN	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
1	1	CD	I-NP	O
GM	GM	NNP	I-NP	O
IV	IV	CD	I-NP	O
Q12H	Q12H	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
last	last	JJ	B-NP	O
day	day	NN	I-NP	O
6/25/07	6/25/07	CD	B-NP	O
ZINC	ZINC	NN	I-NP	B-protein
SULFATE	SULFATE	NN	I-NP	I-protein
220	220	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
1	1	CD	I-NP	O
hour	hour	NN	I-NP	O
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
meals	meal	NNS	B-NP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Hogains	Hogains	NNP	I-NP	O
,	,	,	O	O
ID	ID	NN	B-NP	O
clinic	clinic	NN	I-NP	O
,	,	,	O	O
CMH	CMH	NNP	B-NP	O
Reve	Reve	NNP	I-NP	O
Sen	Sen	NNP	I-NP	O
Cuse	Cuse	NNP	I-NP	O
,	,	,	O	O
190-417-1134	190-417-1134	CD	B-NP	O
July	July	NNP	I-NP	O
at	at	IN	B-PP	O
2pm	2pm	NN	B-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Droke	Droke	NNP	I-NP	O
,	,	,	O	O
RH	RH	NNP	B-NP	O
,	,	,	O	O
625-262-5882	625-262-5882	CD	B-NP	O
June	June	NNP	I-NP	O
at	at	IN	B-PP	O
2	2	CD	B-NP	O
:	:	:	O	O
40	40	CD	B-NP	O
pm	pm	NN	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Mede	Mede	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
spine	spine	NN	I-NP	O
clinic	clinic	NN	I-NP	O
AK	AK	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
January	January	NNP	I-NP	O
@	@	VBD	B-VP	O
8	8	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
am	am	NN	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
DYAZIDE	DYAZIDE	NNP	B-NP	O
,	,	,	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
NSAIDs	NSAIDs	NNP	B-NP	O
,	,	,	O	O
Erythromycins	Erythromycins	NNP	B-NP	O
,	,	,	O	O
AZITHROMYCIN	AZITHROMYCIN	NNP	B-NP	O
,	,	,	O	O
Tape	Tape	NNP	B-NP	O
,	,	,	O	O
IBUPROFEN	IBUPROFEN	NNP	B-NP	O
,	,	,	O	O
KETOROLAC	KETOROLAC	NNP	B-NP	O
TROMETHAMINE	TROMETHAMINE	NNP	I-NP	O
,	,	,	O	O
BUPROPION	BUPROPION	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
,	,	,	O	O
GABAPENTIN	GABAPENTIN	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
noncardiac	noncardiac	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
fibromyalgia	fibromyalgia	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
fibromyalgia	fibromyalgia	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
gastric	gastric	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
gastric	gastric	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
surgery	surgery	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
obesity	obesity	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
anemia	anemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
anemia	anemia	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
spinal	spinal	JJ	I-NP	B-protein
stenosi	stenosi	NNS	I-NP	I-protein
-LRB-	-LRB-	TO	B-PP	I-protein
spinal	spinal	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CAD	CAD	NN	I-NP	O
s/p	s/p	NN	I-NP	O
MI	MI	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
stent	stent	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
stent	stent	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Hyperlipidemia	Hyperlipidemia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
anxiety	anxiety	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
anxiety	anxiety	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
TAH	TAH	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hysterectomy	hysterectomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
ccy	ccy	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
cholecystectomy	cholecystectomy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
**	**	SYM	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
chest	ch	JJS	B-NP	O
pain	pain	NN	I-NP	O
**	**	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
58F	58F	NN	B-NP	O
h/o	h/o	NN	I-NP	O
gastric	gastric	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
,	,	,	O	O
fibromyalgia	fibromyalgia	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
recent	recent	JJ	I-NP	O
laminectomy	laminectomy	NN	I-NP	O
and	and	CC	I-NP	O
washout	washout	NN	I-NP	O
for	for	IN	B-PP	O
infected	infected	JJ	B-NP	O
seroma	seroma	NN	I-NP	O
and	and	CC	I-NP	O
washout	washout	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
's	's	POS	B-VP	O
had	have	VBD	I-VP	O
frequent	frequent	JJ	B-NP	O
admissions	admission	NNS	I-NP	O
for	for	IN	B-PP	O
atypical	atypical	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
at	at	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
hospitals	hospital	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
DOA	DOA	NN	B-NP	B-protein
,	,	,	O	O
noted	note	VBD	B-VP	O
that	that	IN	B-SBAR	O
at	at	IN	B-PP	O
exactly	exactly	RB	B-NP	O
1	1	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
PM	PM	NN	I-NP	O
had	have	VBD	B-VP	O
sudden	sudden	JJ	B-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
sscp	sscp	NN	B-NP	O
10/10	10/10	CD	I-NP	O
which	which	WDT	B-NP	O
she	she	PRP	B-NP	O
described	describe	VBD	B-VP	O
as	as	IN	B-PP	O
someone	someone	NN	B-NP	O
sitting	sit	VBG	B-VP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
and	and	CC	O	O
stabbing	stab	VBG	B-VP	O
her	her	PRP	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
pain	pain	NN	I-NP	O
lasted	last	VBN	B-VP	O
through	through	IN	B-PP	O
2	2	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
nitro	nitro	NN	B-NP	O
sl	sl	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
3rd	3rd	JJ	I-NP	O
dose	dose	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ED	ED	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
finally	finally	RB	I-VP	O
relieved	relieve	VBN	I-VP	O
by	by	IN	B-PP	O
morphine	morphine	NN	B-NP	O
.	.	.	O	O

**	**	SYM	O	O
In	In	IN	B-PP	O
ED	ED	NN	B-NP	O
:	:	:	O	O
60	60	CD	B-NP	O
,	,	,	I-NP	O
18124/71	18124/71	CD	I-NP	O
,	,	,	I-NP	O
99	99	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
given	give	VBN	B-NP	O
morphine	morphine	NN	I-NP	O
2mg	2mg	NN	I-NP	O
IV	IV	CD	I-NP	O
x	x	NN	I-NP	O
3	3	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
morphine	morphine	NN	B-NP	O
4	4	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
x	x	NN	I-NP	O
3	3	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
lopressor	lopressor	NN	B-NP	O
x	x	SYM	O	O
1	1	CD	B-NP	O
,	,	,	O	O
then	then	RB	B-ADVP	O
xanax	xanax	NN	B-NP	B-DNA
x	x	NN	I-NP	I-DNA
1	1	CD	I-NP	I-DNA
.	.	.	O	O

Pain	Pain	NNP	B-NP	O
relieved	relieve	VBD	B-VP	O
4	4	CD	B-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
start	start	NN	B-NP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
.	.	.	O	O

*****	*****	SYM	B-NP	O
PMHx	PMHx	NN	I-NP	O
:	:	:	O	O
cath	cath	NN	B-NP	O
in	in	IN	B-PP	O
10/22	10/22	CD	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
occlusion	occlusion	NN	I-NP	O
of	of	IN	B-PP	O
LAD	LAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
cypher	cypher	NN	I-NP	O
stent	stent	NN	I-NP	O
.	.	.	O	O

laminectomy	laminectomy	NN	B-NP	O
.	.	.	O	O

chronic	chronic	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

fibromyalgia	fibromyalgia	NNS	B-NP	O
.	.	.	O	O

DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
obese	obese	NN	B-NP	O
,	,	,	O	O
anemia	anemia	NN	B-NP	O
,	,	,	O	O
hyponatremia	hyponatremia	NN	B-NP	O
,	,	,	O	O
tobacco	tobacco	NN	B-NP	O
use	use	NN	I-NP	O
*****	*****	SYM	B-NP	O
PE	PE	NN	I-NP	O
:	:	:	O	O
68	68	CD	B-NP	O
18141/73	18141/73	CD	I-NP	O
99	99	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
GEN	GEN	NN	I-NP	O
:	:	:	O	O
obese	obese	JJ	B-NP	O
woman	woman	NN	I-NP	O
,	,	,	O	O
tearful	tearful	JJ	B-NP	O
,	,	,	I-NP	O
anxious	anxious	JJ	I-NP	O
,	,	,	I-NP	O
heent	heent	JJ	I-NP	O
:	:	:	O	O
mmm	mmm	NN	B-NP	O
,	,	,	O	O
cn	cn	NN	B-NP	O
ii-xii	ii-xii	NN	I-NP	O
intact	intact	JJ	B-ADJP	O
,	,	,	O	O
symmetric	symmetric	JJ	B-ADJP	O
.	.	.	O	O

no	no	DT	B-NP	O
bruit	bruit	NN	I-NP	O
,	,	,	O	O
jvp	jvp	NN	B-NP	O
7-8cm	7-8cm	NN	I-NP	O
,	,	,	O	O
pulm	pulm	NN	B-NP	O
:	:	:	O	O
cta	cta	NN	B-NP	O
bilatearlly	bilatearlly	RB	B-ADVP	O
,	,	,	O	O
Cor	Cor	NNP	B-NP	O
:	:	:	O	O
rrr	rrr	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
m/r/g	m/r/g	NN	I-NP	O
.	.	.	O	O

abd	abd	NN	B-NP	O
obese	obese	JJ	I-NP	O
s/p	s/p	NN	I-NP	O
surgery	surgery	NN	I-NP	O
.	.	.	O	O

ext	ext	RB	B-ADVP	O
:	:	:	O	O
bronzing	bronze	VBG	B-VP	O
LE	LE	NN	B-NP	O
,	,	,	O	O
+2	+2	CD	B-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

neuro	neuro	JJ	B-NP	B-protein
intact	intact	JJ	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
decreased	decrease	VBD	B-VP	O
sensation	sensation	NN	B-NP	B-protein
bilateral	bilateral	JJ	I-NP	I-protein
lower	low	JJR	I-NP	I-protein
extremities	extremity	NNS	I-NP	I-protein
-RRB-	-RRB-	NNPS	I-NP	I-protein
*****	*****	SYM	B-NP	I-protein
Labs	Lab	NNPS	I-NP	I-protein
:	:	:	O	O
CK	CK	NN	B-NP	O
:	:	:	O	O
89	89	CD	B-NP	O
CKMB	CKMB	NN	I-NP	O
:	:	:	O	O
7.9	7.9	CD	B-NP	O
TNI	TNI	NN	I-NP	O
<	<	JJR	B-NP	O
0.10	0.10	CD	I-NP	O
WBC	WBC	NNP	I-NP	O
10	10	CD	I-NP	O
,	,	,	O	O
HCT	HCT	NN	B-NP	O
33	33	CD	I-NP	O
=	=	SYM	B-VP	O
>	>	SYM	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
on	on	IN	B-PP	O
5/3	5/3	CD	B-NP	O
CXR	CXR	NN	I-NP	O
:	:	:	O	O
nothing	nothing	NN	B-NP	O
acute	acute	JJ	I-NP	O
-	-	HYPH	I-NP	O
L	L	NN	I-NP	O
sided	sided	JJ	I-NP	O
pacer	pacer	NN	I-NP	O
,	,	,	O	O
R	R	NN	B-NP	B-protein
sided	side	VBD	B-VP	O
PICC	PICC	NN	B-NP	O
In	In	IN	B-PP	O
SVC	SVC	NN	B-NP	O
PE-CT	PE-CT	NN	I-NP	O
:	:	:	O	O
neg	neg	NN	B-NP	O
for	for	IN	B-PP	O
PE	PE	NN	B-NP	O
.	.	.	O	O

unable	unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
for	for	IN	B-PP	O
DVT	DVT	NNP	B-NP	O
EKG	EKG	NNP	I-NP	O
:	:	:	O	O
most	most	RBS	B-VP	O
vpaced	vpace	VBN	I-VP	O
but	but	IN	B-PP	O
one	one	CD	B-NP	O
in	in	IN	B-PP	O
nsr	nsr	NN	B-NP	O
w	w	NN	I-NP	O
TWI	TWI	NN	I-NP	O
laterally	laterally	RB	B-ADVP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	O
new	new	JJ	B-ADJP	O
in	in	IN	B-PP	O
v3-v6	v3-v6	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

*****	*****	SYM	B-NP	O
Events	Event	NNS	I-NP	O
:	:	:	O	O
5/3	5/3	CD	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RB	B-ADVP	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
.	.	.	O	O

Subsequently	Subsequently	RB	B-NP	O
c/o	c/o	NN	I-NP	O
frequent	frequent	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
that	that	IN	B-NP	O
she	she	PRP	B-NP	O
says	say	VBZ	B-VP	O
are	be	VBP	B-VP	O
relieved	relieve	VBN	I-VP	O
by	by	IN	B-PP	O
NTG	NTG	NN	B-NP	B-protein
and	and	CC	I-NP	O
morphine	morphine	NN	I-NP	O
,	,	,	O	O
suspect	suspect	VB	B-VP	O
noncardiac	noncardiac	JJ	B-ADJP	O
.	.	.	O	O

MIBI	MIBI	NN	B-NP	B-protein
results	result	VBZ	B-VP	O
4/20/07	4/20/07	CD	B-NP	O
:	:	:	O	O
normal	normal	JJ	B-NP	O
perfusion	perfusion	NN	I-NP	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
EF	EF	NN	I-NP	O
,	,	,	O	O
area	area	NN	B-NP	O
of	of	IN	B-PP	O
abnormal	abnormal	JJ	B-NP	O
uptake	uptake	NN	I-NP	O
in	in	IN	B-PP	O
L	L	NN	B-NP	O
axilla	axilla	NN	I-NP	O
,	,	,	O	O
recommended	recommend	VBD	B-VP	O
mammogram	mammogram	NN	B-NP	O
*****	*****	SYM	B-NP	O
IMPRESSION	IMPRESSION	NN	I-NP	O
:	:	:	O	O
Ms.	Ms.	NNP	B-NP	O
Denna	Denna	NNP	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
58F	58F	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
h/o	h/o	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
stent	stent	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	B-protein
in	in	IN	B-PP	O
2004	2004	CD	B-NP	O
,	,	,	O	O
permanent	permanent	JJ	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
for	for	IN	B-PP	O
?	?	.	O	O

afib/SSS	afib/SSS	RB	B-ADVP	O
,	,	,	O	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
that	that	IN	B-NP	O
she	she	PRP	B-NP	O
described	describe	VBD	B-VP	O
as	as	RB	B-PP	O
exactly	exactly	RB	B-ADVP	O
like	like	IN	B-PP	O
her	her	PRP$	B-NP	O
MI	MI	NN	I-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
ckmb	ckmb	NN	I-NP	O
elevated	elevate	VBN	B-VP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
she	she	PRP	B-NP	O
also	also	RB	B-ADVP	O
stated	state	VBD	B-VP	O
that	that	DT	O	O
her	her	PRP$	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
had	have	VBD	B-VP	O
never	never	RB	I-VP	O
really	really	RB	I-VP	O
resolved	resolve	VBN	I-VP	O
after	after	IN	B-PP	O
her	her	PRP$	B-NP	O
cath	cath	NN	I-NP	O
in	in	IN	B-PP	O
2004	2004	CD	B-NP	O
.	.	.	O	O

Complicating	Complicate	VBG	B-NP	O
factors	factor	NNS	I-NP	O
include	include	VBP	B-VP	O
multiple	multiple	JJ	B-NP	O
admissions	admission	NNS	I-NP	O
for	for	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
pain	pain	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
narcotic	narcotic	JJ	B-NP	O
dependence	dependence	NN	I-NP	O
.	.	.	O	O

**	**	SYM	B-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
i	i	NN	B-NP	O
:	:	:	O	O
Initially	Initially	RB	B-ADVP	O
there	there	EX	B-NP	O
was	be	VBD	B-VP	O
concern	concern	NN	B-NP	O
b/c	b/c	NN	I-NP	O
her	her	PRP$	B-NP	O
CKMB	CKMB	NN	I-NP	B-protein
fraction	fraction	NN	I-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
T	T	NN	B-NP	O
wave	wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
in	in	IN	B-PP	O
V3-V6	V3-V6	NN	B-NP	O
that	that	WDT	B-NP	O
seemed	seem	VBD	B-VP	O
new	new	JJ	B-ADJP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
non-paced	non-paced	JJ	I-NP	O
EKG	EKG	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
captured	capture	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
received	receive	VBD	B-VP	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
therapeutic	therapeutic	JJ	B-NP	O
lovenox	lovenox	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
when	when	WRB	B-ADVP	O
she	she	PRP	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
.	.	.	O	O

She	She	PRP	B-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
throughout	throughout	IN	B-PP	O
her	her	PRP$	B-NP	O
admission	admission	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
typically	typically	RB	B-ADVP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
relieved	relieve	VBN	I-VP	O
by	by	IN	B-PP	O
morphine	morphine	NN	B-NP	O
.	.	.	O	O

Suspicion	Suspicion	NN	B-NP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
chest	chest	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
low	low	JJ	B-ADJP	O
,	,	,	O	O
but	but	CC	O	O
a	a	DT	B-NP	O
MIBI	MIBI	NNP	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
to	to	TO	B-VP	O
determine	determine	VB	I-VP	O
her	her	PRP$	B-NP	O
baseline	baseline	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
MIBI	MIBI	NNP	I-NP	O
revealed	reveal	VBD	B-VP	O
normal	normal	JJ	B-NP	O
perfusion	perfusion	NN	I-NP	O
and	and	CC	O	O
normal	normal	JJ	B-NP	O
EF	EF	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
abnormal	abnormal	JJ	B-NP	O
uptake	uptake	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
axilla	axilla	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
obtaining	obtain	VBG	B-VP	O
a	a	DT	B-NP	O
mammogram	mammogram	NN	I-NP	O
was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
.	.	.	O	O

**	**	SYM	B-NP	O
NEURO	NEURO	NN	I-NP	B-protein
:	:	:	O	O
High	High	JJ	B-NP	O
pain	pain	NN	I-NP	O
med	med	JJ	I-NP	O
requirements	requirement	NNS	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
chronic	chronic	JJ	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
surgical	surgical	JJ	B-NP	O
interventions	intervention	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
regimen	regimen	NN	B-NP	O
as	as	IN	B-SBAR	O
outlined	outline	VBN	B-VP	O
in	in	IN	B-PP	O
last	last	JJ	B-NP	O
d/c	d/c	NN	I-NP	O
summary	summary	NN	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
MS	MS	NN	B-NP	O
Contin	Contin	NN	I-NP	O
30mg	30mg	CD	B-NP	O
BID	BID	NN	I-NP	O
and	and	CC	O	O
oxycodone	oxycodone	NN	B-NP	B-protein
30mg	30mg	CD	I-NP	I-protein
po	po	NN	I-NP	I-protein
q4h	q4h	NN	I-NP	I-protein
prn	prn	NN	I-NP	I-protein
pain	pain	NN	I-NP	I-protein
.	.	.	O	O

Pain	Pain	NN	B-NP	O
service	service	NN	I-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
see	see	VB	I-VP	O
her	her	PRP	B-NP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
and	and	CC	O	O
recommended	recommend	VBD	B-VP	O
outpatient	outpatient	NN	B-NP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
either	either	CC	O	O
rheumatology	rheumatology	NN	B-NP	O
or	or	CC	I-NP	O
psychiatry	psychiatry	NN	I-NP	O
re	re	VBP	B-VP	O
her	her	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
pain	pain	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
and	and	CC	I-NP	O
fibromyalgia	fibromyalgia	NN	I-NP	O
.	.	.	O	O

Bladder	Bladder	NN	B-NP	O
training	training	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
considered	consider	VBN	I-VP	O
given	give	VBN	B-PP	O
her	her	PRP$	B-NP	O
urinary	urinary	JJ	I-NP	O
incontinence	incontinence	NN	I-NP	O
.	.	.	O	O

**	**	SYM	B-NP	B-protein
ORTHO	ORTHO	NN	I-NP	I-protein
:	:	:	O	O
recent	recent	JJ	B-NP	O
procedure	procedure	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
10/24	10/24	CD	I-NP	O
L3-L5	L3-L5	NN	I-NP	O
laminectomy	laminectomy	NN	I-NP	O
for	for	IN	B-PP	O
cauda	cauda	NNP	B-NP	O
equina	equina	NNP	I-NP	O
,	,	,	I-NP	O
I	I	NNP	I-NP	O
&	&	CC	I-NP	O
D	D	NNP	I-NP	O
for	for	IN	B-PP	O
seroma	seroma	NN	B-NP	O
7/8	7/8	CD	I-NP	O
.	.	.	O	O

Orthopedics	Orthopedic	NNS	B-NP	O
followed	follow	VBN	B-VP	O
while	while	IN	B-SBAR	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
small	small	JJ	I-NP	O
protrusion	protrusion	NN	I-NP	O
likely	likely	RB	B-NP	O
muscle	muscle	NN	I-NP	O
herniation	herniation	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
site	site	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
recent	recent	JJ	I-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Loendorf	Loendorf	NNP	I-NP	O
ID	ID	NNP	I-NP	O
saw	see	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
will	will	MD	B-VP	O
see	see	VB	I-VP	O
her	her	PRP	B-NP	O
in	in	IN	B-PP	O
follow	follow	VB	B-VP	O
up	up	IN	B-PRT	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	I-VP	O
continue	continue	VB	I-VP	O
the	the	DT	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
through	through	IN	B-PP	O
6/25/07	6/25/07	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
then	then	RB	O	O
the	the	DT	B-NP	O
vancomycin	vancomycin	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
PICC	PICC	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
discontinued	discontinue	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Dininger	Dininger	NNP	I-NP	O
on	on	IN	B-PP	O
July	July	NNP	B-NP	O
.	.	.	O	O

Full	Full	DT	B-NP	O
code	code	VBP	B-VP	O
ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	O
were	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Ra	Ra	NNP	B-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
with	with	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
was	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
and	and	CC	O	O
you	you	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
attack	attack	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Fogg	Fogg	NNP	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
scheduled	schedule	VBN	I-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
also	also	RB	I-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Saxfield	Saxfield	NNP	I-NP	O
,	,	,	O	O
infectious	infectious	JJ	B-NP	O
disease	disease	NN	I-NP	O
specialist	specialist	NN	I-NP	O
,	,	,	O	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
scheduled	schedule	VBN	I-NP	O
appointment	appointment	NN	I-NP	O
.	.	.	O	O

Call	Call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
or	or	CC	O	O
return	return	VB	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Emergency	Emergency	NNP	I-NP	O
Department	Department	NNP	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
any	any	DT	B-NP	O
severe	severe	JJ	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
fainting	fainting	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
concerning	concern	VBG	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	O
need	need	VBP	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
mammogram	mammogram	NN	I-NP	O
done	do	VBN	B-VP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
ask	ask	VB	I-VP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
doctor	doctor	NN	I-NP	O
to	to	TO	B-VP	O
order	order	VB	I-VP	O
this	this	DT	B-NP	O
Vancomycin	Vancomycin	NN	I-NP	O
stops	stop	VBZ	B-VP	O
1/2/06	1/2/06	CD	B-NP	O
.	.	.	O	O

PICC	PICC	NN	B-NP	O
line	line	NN	I-NP	O
needs	need	VBZ	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
taken	take	VBN	I-VP	O
out	out	RP	B-PRT	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
consider	consider	VBP	B-VP	O
psychiatric	psychiatric	JJ	B-NP	O
or	or	CC	I-NP	O
rheumatologic	rheumatologic	JJ	I-NP	O
follow-up	follow-up	NN	I-NP	O
re	re	VBP	B-VP	O
her	her	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	I-NP	O
fibromyalgia	fibromyalgia	NN	I-NP	B-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
consider	consider	VBP	B-VP	O
outpatient	outpatient	NN	B-NP	O
bladder	bladder	NN	I-NP	O
training	training	NN	I-NP	O
re	re	VB	B-VP	O
her	her	PRP$	B-NP	B-protein
urinary	urinary	JJ	I-NP	I-protein
incontinence	incontinence	NN	I-NP	I-protein
3	3	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
please	please	NN	I-NP	O
order	order	NN	I-NP	O
mammogram	mammogram	NN	I-NP	O
,	,	,	O	O
abnormal	abnormal	JJ	B-NP	O
uptake	uptake	NN	I-NP	O
in	in	IN	B-PP	O
L	L	NN	B-NP	O
axilla	axilla	NN	I-NP	O
on	on	IN	B-PP	O
MIBI	MIBI	NNP	B-NP	O
No	No	NNP	I-NP	O
dictated	dictate	VBD	B-VP	O
summary	summary	JJ	B-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
SOFKA	SOFKA	NN	B-NP	B-protein
,	,	,	O	O
TED	TED	NNP	B-NP	O
S.	S.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AJ86	AJ86	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
7/9/07	7/9/07	CD	I-NP	O
@	@	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
57	57	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

